US Stock MarketDetailed Quotes

BAX Baxter International Inc

Watchlist
  • 42.770
  • +0.080+0.19%
Trading Mar 28 09:54 ET
21.78BMarket Cap8.15P/E (TTM)

About Baxter International Inc Company

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Company Profile

SymbolBAX
Company NameBaxter International Inc
Listing Date05/15/1961
Founded1931
CEOMr. Jose E. Almeida
MarketNYSE
Employees60000
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressOne Baxter Parkway
CityDeerfield
ProvinceIllinois
CountryUnited States of America
Zip Code60015-4625
Phone1-224-948-2000

Company Executives

  • Name
  • Position
  • Salary
  • Jose E. Almeida
  • Chairman of the Board, Chief Executive Officer and President
  • 13.79M
  • Jeanne K. Mason
  • Executive Vice President and Chief Human Resources Officer
  • --
  • James W. Borzi
  • Executive Vice President and Chief Supply Chain Officer
  • --
  • Brian C. Stevens
  • Senior Vice President, Chief Accounting Officer and Controller
  • 2.53M
  • Joel T. Grade
  • Executive Vice President and Chief Financial Officer
  • 4.88M
  • Alok Sonig
  • Executive Vice President and Group President, Pharmaceuticals
  • 3.87M
  • Christopher A. Toth
  • Executive Vice President and Group President, Kidney Care
  • 9.64M
  • Heather L. Knight
  • Executive Vice President and Group President, Medical Products and Therapies
  • 4.86M
  • David S. Rosenbloom
  • Executive Vice President and General Counsel
  • 5.56M
  • Reazur Rasul
  • Executive Vice President and Group President, Healthcare Systems and Technologies
  • --
  • Patricia B. Morrison
  • Independent Director
  • 364.98K
  • Peter M. Wilver
  • Independent Director
  • 349.64K
  • Dr. Stephen Newman Oesterle, M.D.
  • Independent Director
  • 373.98K
  • Amy A. Wendell
  • Independent Director
  • 352.98K
  • Nancy M. Schlichting
  • Independent Director
  • 363.00K
  • Stephen H. Rusckowski
  • Independent Director
  • 197.82K
  • Cathy R. Smith
  • Independent Director
  • 367.31K
  • D. Brent Shafer
  • Lead Independent Director
  • 382.31K
  • Dr. David S. Wilkes
  • Independent Director
  • 357.00K
  • William A. Ampofo, II
  • Independent Director
  • 226.35K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg